Form 4: USANA CEO Kevin Guest Granted 82,726 RSUs

USANA Health Sciences CEO and Executive Chairman, Kevin Guest, was granted 82,726 restricted stock units, aligning executive incentives with shareholder value.

Summary

• Kevin Guest, the CEO and Executive Chairman of USANA Health Sciences Inc. (USNA), was granted 82,726 Restricted Stock Units (RSUs) on February 19, 2026.
• Each RSU represents a contingent right to receive one share of USNA common stock.
• The granted RSUs will vest at 25% on each February 19th thereafter, starting from February 19, 2027.
• Following this transaction, Kevin Guest beneficially owns a total of 135,062 derivative securities.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment and aligns leadership incentives with the company's long-term performance, which is generally favorable for shareholders.

Positives

• The grant of 82,726 Restricted Stock Units to CEO and Executive Chairman Kevin Guest aligns management's long-term interests directly with shareholder value.
• The multi-year vesting schedule promotes executive retention and incentivizes sustained company performance over time.

Future Outlook

The granted Restricted Stock Units are subject to a multi-year vesting schedule, with 25% vesting annually on February 19th, starting in 2027, indicating a long-term incentive structure for the CEO.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units to a key executive like the CEO is a common practice in the direct selling and health sciences industry to incentivize long-term performance and align leadership interests with shareholder returns. This type of compensation structure is prevalent across publicly traded companies to retain top talent and encourage strategic growth.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a significant component of executive compensation is a standard practice across various industries, including health and wellness, similar to grants observed at companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS).
• The multi-year vesting schedule (25% annually over four years) is typical for executive equity awards, designed to promote long-term commitment and performance, comparable to vesting schedules seen in tech or pharmaceutical companies for their senior leadership.

Stakeholder Impact

• Shareholders: The grant aligns the CEO's financial interests with the company's stock performance, potentially leading to more shareholder-friendly decisions and long-term value creation.
• Management (Kevin Guest): Provides a significant long-term incentive and compensation component, encouraging continued dedication to the company's success.

Next Steps

• The Restricted Stock Units will vest at 25% annually on February 19th, beginning February 19, 2027.

Key Dates

Recommendation

While the RSU grant is a positive signal of executive alignment and retention, a Form 4 filing alone typically does not warrant a change in investment recommendation. It reinforces a 'hold' stance by indicating stable corporate governance and executive incentives, but lacks broader financial or operational data to justify a 'buy' or 'sell' decision.

Keywords

USANA Health Sciences, USNA, Kevin Guest, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Form 4, Beneficial Ownership